TY - JOUR
T1 - Hematopoietic stem-cell transplantation in the resource-limited setting
T2 - Establishing the first bone marrow transplantation unit in Bangladesh
AU - Yeh, Albert C.
AU - Khan, Mohiuddin A.
AU - Harlow, Jason
AU - Caron, Martin
AU - Ara, Tasneem
AU - Moran, Jenna
AU - Islam, Manirul
AU - Brezina, Mark
AU - Akter, Mafruha
AU - Biswas, Akhil R.
AU - Ferdous, Jannatul
AU - Barron, Anne Marie
AU - Nazneen, Humayra
AU - Kamruzzaman, Md
AU - Saha, Anup
AU - Marshall, Ariela
AU - Afrose, Salma
AU - Stowell, Christopher
AU - Preffer, Frederic
AU - Bangsberg, David
AU - Goodman, Annekathryn
AU - Attar, Eyal
AU - McAfee, Steven
AU - Spitzer, Thomas R.
AU - Dey, Bimalangshu R.
N1 - Publisher Copyright:
© 2016 by American Society of Clinical Oncology
PY - 2018/3/1
Y1 - 2018/3/1
N2 - Purpose Treatment of malignant and nonmalignant hematologic diseases with hematopoietic stem-cell transplantation (HSCT) was first described almost 60 years ago, and its use has expanded significantly over the last 20 years. Whereas HSCT has become the standard of care for many patients in developed countries, the significant economic investment, infrastructure, and health care provider training that are required to provide such a service have prohibited it from being widely adopted, particularly in developing countries. Methods Over the past two decades, however, efforts to bring HSCT to the developing world have increased, and several institutions have described their efforts to establish such a program. We aim to provide an overview of the current challenges and applications of HSCT in developing countries as well as to describe our experience in developing an HSCT program at Dhaka Medical College and Hospital in Bangladesh via a partnership with health care providers at Massachusetts General Hospital. Results and Conclusion We discuss key steps of the program, including the formation of a collaborative partnership, infrastructure development, human resource capacity building, and financial considerations.
AB - Purpose Treatment of malignant and nonmalignant hematologic diseases with hematopoietic stem-cell transplantation (HSCT) was first described almost 60 years ago, and its use has expanded significantly over the last 20 years. Whereas HSCT has become the standard of care for many patients in developed countries, the significant economic investment, infrastructure, and health care provider training that are required to provide such a service have prohibited it from being widely adopted, particularly in developing countries. Methods Over the past two decades, however, efforts to bring HSCT to the developing world have increased, and several institutions have described their efforts to establish such a program. We aim to provide an overview of the current challenges and applications of HSCT in developing countries as well as to describe our experience in developing an HSCT program at Dhaka Medical College and Hospital in Bangladesh via a partnership with health care providers at Massachusetts General Hospital. Results and Conclusion We discuss key steps of the program, including the formation of a collaborative partnership, infrastructure development, human resource capacity building, and financial considerations.
UR - http://www.scopus.com/inward/record.url?scp=85053767218&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053767218&partnerID=8YFLogxK
U2 - 10.1200/JGO.2016.006460
DO - 10.1200/JGO.2016.006460
M3 - Article
C2 - 30241180
AN - SCOPUS:85053767218
SN - 2378-9506
VL - 2018
SP - 1
EP - 10
JO - Journal of Global Oncology
JF - Journal of Global Oncology
IS - 4
ER -